Everest Medicines
PublicEverest Medicines is now publicly traded
The data on this page reflects Everest Medicines's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Oct 9, 2020
Last Round
Private Placement
Jul 25, 2025
Est. Valuation at Exit
$3.48B
Total Funding Raised
$1.23B
Company Overview
Everest Medicines is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of innovative therapies and vaccines to address critical unmet medical needs.
Sector
Healthcare
AI Layer
Infrastructure
Keywords
Everest Medicines Comparables
Compare Everest Medicines with similar companies based on industry and business-model similarity.
No public comparables are available for Everest Medicines. Request access to learn about comparables coverage.
Request accessEverest Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 25, 2025 | ||||
| IPO | Oct 9, 2020 | ||||
| Series C | Jun 4, 2020 | ||||
| Series B | Jun 1, 2019 | ||||
| Series A | Jun 20, 2018 |
Everest Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | IPO, Series C |
| Hillhouse Investment | Series C |
| CBC Group | Private Placement, IPO, Series C, Series B, Series A |
| OrbiMed | IPO |
| GIC Private Limited | IPO |
| HBM Healthcare Investments | Series A, Series C, Series B |
Everest Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access